| Q1 FY27 | Jul 31, 2026 | 28 | +366.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY26 | Apr 30, 2026 | 18 | 0.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY26 | Jan 31, 2026 | 10 | -16.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY26 | Oct 31, 2025 | 6 | -45.5% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY26 | Jul 31, 2025 | 6 | -85.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY25 | Apr 30, 2025 | 18 | +100.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY25 | Jan 31, 2025 | 12 | -25.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY25 | Oct 31, 2024 | 11 | -21.4% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY25 | Jul 31, 2024 | 42 | -68.4% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY24 | Apr 30, 2024 | 9 | -50.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY24 | Jan 31, 2024 | 16 | -5.9% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY24 | Oct 31, 2023 | 14 | +40.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY24 | Jul 31, 2023 | 133 | +3,225.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY23 | Apr 30, 2023 | 18 | +500.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY23 | Jan 31, 2023 | 17 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY23 | Oct 31, 2022 | 10 | +233.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY23 | Jul 31, 2022 | 4 | +100.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY22 | Apr 30, 2022 | 3 | -75.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY22 | Jan 31, 2022 | 0 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY22 | Oct 31, 2021 | 3 | 0.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY22 | Jul 31, 2021 | 2 | -84.6% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY21 | Apr 30, 2021 | 12 | -50.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY21 | Jan 31, 2021 | 0 | -100.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY21 | Oct 31, 2020 | 3 | -98.4% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY21 | Jul 31, 2020 | 13 | +116.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY20 | Apr 30, 2020 | 24 | +242.9% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY20 | Jan 31, 2020 | 4 | +300.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY20 | Oct 31, 2019 | 193 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY20 | Jul 31, 2019 | 6 | -91.2% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY19 | Apr 30, 2019 | 7 | -41.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY19 | Jan 31, 2019 | 1 | 0.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY19 | Oct 31, 2018 | 0 | -100.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY19 | Jul 31, 2018 | 68 | +871.4% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY18 | Apr 30, 2018 | 12 | -40.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY18 | Jan 31, 2018 | 1 | -75.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY18 | Oct 31, 2017 | 2 | -66.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY18 | Jul 31, 2017 | 7 | 0.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY17 | Apr 30, 2017 | 20 | +185.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY17 | Jan 31, 2017 | 4 | -20.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY17 | Oct 31, 2016 | 6 | -45.5% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY17 | Jul 31, 2016 | 7 | 0.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY16 | Apr 30, 2016 | 7 | +40.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY16 | Jan 31, 2016 | 5 | +25.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY16 | Oct 31, 2015 | 11 | +83.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY16 | Jul 31, 2015 | 7 | -80.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY15 | Apr 30, 2015 | 5 | -68.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY15 | Jan 31, 2015 | 4 | +100.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY15 | Oct 31, 2014 | 6 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY15 | Jul 31, 2014 | 35 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY14 | Apr 30, 2014 | 16 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY14 | Jan 31, 2014 | 2 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|